Siplizumab Biosimilar - Research Grade

Human

CD2ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P06729

Blue ice

CD2 is an adhesion and costimulatory receptor on T and NK cells that contributes to immune-synapse formation and T-cell activation. The reagent here is a non-therapeutic, unconjugated analog of siplizumab, a recombinant anti-CD2 monoclonal antibody intended for research use only. It is manufactured to in vivo standards in a low-endotoxin format and offered in scalable milligram to gram quantities for heavy-usage laboratories. Researchers apply it in T-cell modulation and depletion functional assays, in vitro immunophenotyping screens, and in vivo models of transplantation tolerance and autoimmunity. Uniform, reproducible material supports robust experimental design at research scale.

LFA-2, SRBC, T11, CD2 molecule

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks